Jove
Visualize
Contact Us

Related Experiment Videos

Selective factor Xa inhibitors: practical guidelines for use

Louis M Kwong1

  • 1Department of Orthopaedic Surgery, Harbor/UCLA Medical Center Torrance, California, USA.

American Journal of Orthopedics (Belle Mead, N.J.)
|December 5, 2002
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Current illicit drug use profile of orthopaedic trauma patients and its effect on hospital length of stay.

Injury·2020
Same author

A post-marketing assessment of major bleeding in total hip and total knee replacement surgery patients receiving rivaroxaban.

Current medical research and opinion·2017
Same author

Postorthopedic Surgery Joint Replacement Surgery Venous Thromboembolism Prophylaxis.

Hematology/oncology clinics of North America·2016
Same author

Opioid abuse-deterrent strategies: role of clinicians in acute pain management.

Postgraduate medicine·2015
Same author

Comparative safety and efficacy of antithrombotics in the management of venous thromboembolism after knee or hip replacement surgery: focus on rivaroxaban.

Clinical pharmacology : advances and applications·2013
Same author

Rivaroxaban, an oral, direct factor Xa inhibitor: a new option for thromboprophylaxis.

Orthopedics·2012
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies